Comparing 2 hypotheses side-by-side
## Mechanistic Overview Pericyte Contractility Reset via Selective PDGFR-β Agonism starts from the claim that modulating PDGFRB within the disease context of neurodegeneration can redirect a disease-relevant process. The original description reads: "## **Molecular Mechanism and Rationale** Pericytes are contractile cells that wrap around capillaries and play a crucial role in maintaining blood-brain barrier (BBB) integrity, regulating cerebral blood flow, and facilitating interstitial fluid drai
CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau pathology and exploitable as a 'zero-stage' biomarker via ADAM10/17-mediated ectodomain shedding. Biomarker utility is strong; therapeutic translation requires novel PDGFR-β agonism or ADAM10/17-selective CNS inhibition.
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | Pericyte Contractility Reset v | Pericyte-First Sequential Biom |
|---|---|---|
| Mechanistic | 0.500 | 0.820 |
| Evidence | 0.450 | 0.180 |
| Novelty | 0.900 | 0.760 |
| Feasibility | 0.300 | 0.680 |
| Impact | 0.600 | 0.000 |
| Druggability | 0.250 | 0.420 |
| Safety | 0.350 | 0.480 |
| Competition | 0.950 | 0.650 |
| Data | 0.550 | 0.800 |
| Reproducible | 0.500 | 0.740 |
| KG Connect | 0.706 | 0.500 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.93
# Novel Therapeutic Hypotheses for Perivascular Spaces and Glymphatic Clearance in AD ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation **Description:** Chronic activation of ...
# Novel Therapeutic Hypotheses for Perivascular Spaces and Glymphatic Clearance in AD ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation **Description:** Chronic activation of ...
# Critical Scientific Evaluation of Glymphatic Therapeutic Hypotheses ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation ### Critical Weaknesses: - **Mechanistic gap**: The con...
# Critical Scientific Evaluation of Glymphatic Therapeutic Hypotheses ## 1. Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation ### Critical Weaknesses: - **Mechanistic gap**: The con...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["PDGFR-beta Selective Agonist"]
B["PDGFR-beta Receptor Activation"]
C["PLCgamma Pathway Activation"]
D["IP3 and DAG Generation"]
E["Calcium Mobilization"]
F["Protein Kinase C Activation"]
G["Myosin Light Chain Phosphorylation"]
H["Pericyte Contractility Enhancement"]
I["Blood-Brain Barrier Stabilization"]
J["Glymphatic Flow Restoration"]
K["Amyloid-beta Clearance"]
L["Neuroinflammation Reduction"]
M["Synaptic Protection"]
N["Cognitive Function Improvement"]
O["Neurodegeneration Progression Halt"]
P["PI3K/Akt Pathway Inhibition"]
A -->|"therapeutic intervention"| B
B -->|"selective signaling"| C
B -->|"alternative pathway"| P
C -->|"phospholipase activation"| D
D -->|"second messenger generation"| E
D -->|"protein kinase activation"| F
E -->|"intracellular Ca2+ increase"| G
F -->|"contractile protein regulation"| G
G -->|"smooth muscle contraction"| H
H -->|"vascular tone restoration"| I
H -->|"perivascular space regulation"| J
I -->|"barrier function improvement"| K
J -->|"interstitial fluid drainage"| K
K -->|"protein aggregate removal"| L
L -->|"neuroprotective environment"| M
M -->|"neuronal preservation"| N
N -->|"functional recovery"| O
P -->|"proliferation inhibition"| H
classDef mechanism fill:#4fc3f7
classDef pathology fill:#ef5350
classDef therapy fill:#81c784
classDef outcome fill:#ffd54f
classDef genetics fill:#ce93d8
class A,B,C,D,E,F,G,P therapy
class H,I,J mechanism
class K,L,M outcome
class N,O outcome